ID   MRC2_MOUSE              Reviewed;        1479 AA.
AC   Q64449; A2AAB0; Q6ZQ64; Q8C6P0;
DT   07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   03-AUG-2022, entry version 164.
DE   RecName: Full=C-type mannose receptor 2;
DE   AltName: Full=Lectin lambda;
DE   AltName: Full=Macrophage mannose receptor 2;
DE   AltName: CD_antigen=CD280;
DE   Flags: Precursor;
GN   Name=Mrc2; Synonyms=Kiaa0709;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=8702911; DOI=10.1074/jbc.271.35.21323;
RA   Wu K., Yuan J., Lasky L.A.;
RT   "Characterization of a novel member of the macrophage mannose receptor type
RT   C lectin family.";
RL   J. Biol. Chem. 271:21323-21330(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Oviduct;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 479-1479 (ISOFORM 1).
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [5]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=12835757; DOI=10.1038/sj.embor.embor882;
RA   East L., McCarthy A., Wienke D., Sturge J., Ashworth A., Isacke C.M.;
RT   "A targeted deletion in the endocytic receptor gene Endo180 results in a
RT   defect in collagen uptake.";
RL   EMBO Rep. 4:710-716(2003).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12668656; DOI=10.1083/jcb.200211091;
RA   Engelholm L.H., List K., Netzel-Arnett S., Cukierman E., Mitola D.J.,
RA   Aaronson H., Kjoller L., Larsen J.K., Yamada K.M., Strickland D.K.,
RA   Holmbeck K., Danoe K., Birkedal-Hansen H., Behrendt N., Bugge T.H.;
RT   "uPARAP/Endo180 is essential for cellular uptake of collagen and promotes
RT   fibroblast collagen adhesion.";
RL   J. Cell Biol. 160:1009-1015(2003).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=14729061; DOI=10.1016/j.yexcr.2003.10.008;
RA   Kjoller L., Engelholm L.H., Hoyer-Hansen M., Danoe K., Bugge T.H.,
RA   Behrendt N.;
RT   "uPARAP/endo180 directs lysosomal delivery and degradation of collagen
RT   IV.";
RL   Exp. Cell Res. 293:106-116(2004).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15967816; DOI=10.1083/jcb.200411153;
RA   Curino A.C., Engelholm L.H., Yamada S.S., Holmbeck K., Lund L.R.,
RA   Molinolo A.A., Behrendt N., Nielsen B.S., Bugge T.H.;
RT   "Intracellular collagen degradation mediated by uPARAP/Endo180 is a major
RT   pathway of extracellular matrix turnover during malignancy.";
RL   J. Cell Biol. 169:977-985(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-139 AND ASN-363.
RC   TISSUE=Myoblast;
RX   PubMed=19656770; DOI=10.1074/mcp.m900195-mcp200;
RA   Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D.,
RA   Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B.;
RT   "The mouse C2C12 myoblast cell surface N-linked glycoproteome:
RT   identification, glycosite occupancy, and membrane orientation.";
RL   Mol. Cell. Proteomics 8:2555-2569(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Lung, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (18 ANGSTROMS).
RX   PubMed=12856000; DOI=10.1038/sj.embor.embor898;
RA   Rivera-Calzada A., Robertson D., MacFadyen J.R., Boskovic J., Isacke C.M.,
RA   Llorca O.;
RT   "Three-dimensional interplay among the ligand-binding domains of the
RT   urokinase-plasminogen-activator-receptor-associated protein, Endo180.";
RL   EMBO Rep. 4:807-812(2003).
CC   -!- FUNCTION: May play a role as endocytotic lectin receptor displaying
CC       calcium-dependent lectin activity. Internalizes glycosylated ligands
CC       from the extracellular space for release in an endosomal compartment
CC       via clathrin-mediated endocytosis. May be involved in plasminogen
CC       activation system controlling the extracellular level of PLAUR/PLAU,
CC       and thus may regulate protease activity at the cell surface. May
CC       contribute to cellular uptake, remodeling and degradation of
CC       extracellular collagen matrices. May participate in remodeling of
CC       extracellular matrix cooperating with the matrix metalloproteinases
CC       (MMPs). {ECO:0000269|PubMed:12668656, ECO:0000269|PubMed:14729061,
CC       ECO:0000269|PubMed:15967816}.
CC   -!- SUBUNIT: Interacts directly with PLAUR/UPAR and PLAU/pro-UPA to form a
CC       tri-molecular complex. Interacts with collagen V and with C-terminal
CC       region of type I collagen/COL1A1 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q64449-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q64449-2; Sequence=VSP_017223, VSP_017224;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, lung and kidney, but
CC       little or no expression in brain, thymus or adult liver. Expressed at
CC       highly endothelialized sites such as those in choroid plexus and kidney
CC       glomerulai as well as in chondrocytes in cartilaginous regions of the
CC       embryo. {ECO:0000269|PubMed:8702911}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed at day 7 of embryonic development
CC       and detected throughout the later stages of embryonic development.
CC       {ECO:0000269|PubMed:8702911}.
CC   -!- DOMAIN: C-type lectin domains 3 to 8 are not required for calcium-
CC       dependent binding of mannose, fucose and N-acetylglucosamine. C-type
CC       lectin domain 2 is responsible for sugar-binding in a calcium-dependent
CC       manner (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: Fibronectin type-II domain mediates collagen-binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: Ricin B-type lectin domain contacts with the second C-type
CC       lectin domain.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice show impaired mammary tumor growth. Tumors
CC       from mice lacking Mrc2 display an abrogation of cellular collagen
CC       uptake, a fibrotic state characterized by the accumulation of both
CC       basement membrane and interstitial collagens, and an overall tumor size
CC       reduction, despite the collagen accumulation. Fibroblasts from mice
CC       lacking Mrc2 display a severe impairment of internalization of collagen
CC       IV and V and thus, exhibit a general deficiency in uptake and delivery
CC       of collagens to vesicular compartments. Fibroblasts also have
CC       diminished initial adhesion to collagen as well as impaired migration
CC       on fibrillar collagen. Mice with a targeted deletion of Mrc2 exon 2-6
CC       are phenotypically normal, healthy and fertile. This deletion resulted
CC       in expression of a protein that lacks the ricin B-type lectin domain,
CC       the fibronectin type-II domain and the first C-type lectin domain.
CC       Fibroblasts from these mice display C-type lectin activity, but have a
CC       defect in collagen-binding and internalization, and an impaired
CC       migratory phenotype. {ECO:0000269|PubMed:12668656,
CC       ECO:0000269|PubMed:12835757, ECO:0000269|PubMed:14729061,
CC       ECO:0000269|PubMed:15967816}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC52729.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAC35672.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Endo180;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_mou_Ctlect_252";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U56734; AAC52729.1; ALT_FRAME; mRNA.
DR   EMBL; AK054150; BAC35672.1; ALT_INIT; mRNA.
DR   EMBL; AL645471; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL645572; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL645684; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK129195; BAC98005.1; -; mRNA.
DR   CCDS; CCDS25539.1; -. [Q64449-1]
DR   PIR; T42710; T42710.
DR   RefSeq; NP_032652.3; NM_008626.3. [Q64449-1]
DR   AlphaFoldDB; Q64449; -.
DR   SMR; Q64449; -.
DR   BioGRID; 201485; 4.
DR   STRING; 10090.ENSMUSP00000097909; -.
DR   GlyConnect; 2240; 3 N-Linked glycans (2 sites).
DR   GlyGen; Q64449; 7 sites, 3 N-linked glycans (2 sites).
DR   iPTMnet; Q64449; -.
DR   PhosphoSitePlus; Q64449; -.
DR   MaxQB; Q64449; -.
DR   PaxDb; Q64449; -.
DR   PeptideAtlas; Q64449; -.
DR   PRIDE; Q64449; -.
DR   ProteomicsDB; 291442; -. [Q64449-1]
DR   ProteomicsDB; 291443; -. [Q64449-2]
DR   Antibodypedia; 31250; 261 antibodies from 30 providers.
DR   DNASU; 17534; -.
DR   Ensembl; ENSMUST00000100335; ENSMUSP00000097909; ENSMUSG00000020695. [Q64449-1]
DR   GeneID; 17534; -.
DR   KEGG; mmu:17534; -.
DR   UCSC; uc007lxi.1; mouse. [Q64449-1]
DR   CTD; 9902; -.
DR   MGI; MGI:107818; Mrc2.
DR   VEuPathDB; HostDB:ENSMUSG00000020695; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT01050000244842; -.
DR   HOGENOM; CLU_002069_2_0_1; -.
DR   InParanoid; Q64449; -.
DR   OMA; GFIWEHI; -.
DR   OrthoDB; 29241at2759; -.
DR   PhylomeDB; Q64449; -.
DR   TreeFam; TF316663; -.
DR   Reactome; R-MMU-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   BioGRID-ORCS; 17534; 0 hits in 73 CRISPR screens.
DR   ChiTaRS; Mrc2; mouse.
DR   PRO; PR:Q64449; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q64449; protein.
DR   Bgee; ENSMUSG00000020695; Expressed in brain meninx and 209 other tissues.
DR   ExpressionAtlas; Q64449; baseline and differential.
DR   Genevisible; Q64449; MM.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; ISO:MGI.
DR   GO; GO:0005518; F:collagen binding; ISO:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0030574; P:collagen catabolic process; ISO:MGI.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   CDD; cd00062; FN2; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 2.10.10.10; -; 1.
DR   Gene3D; 3.10.100.10; -; 8.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF00059; Lectin_C; 8.
DR   SMART; SM00034; CLECT; 8.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF56436; SSF56436; 8.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 3.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 8.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Disulfide bond; Endocytosis; Glycoprotein;
KW   Isopeptide bond; Lectin; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..1479
FT                   /note="C-type mannose receptor 2"
FT                   /id="PRO_0000046079"
FT   TOPO_DOM        31..1413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1414..1434
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1435..1479
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          37..190
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DOMAIN          181..229
FT                   /note="Fibronectin type-II"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DOMAIN          243..359
FT                   /note="C-type lectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          388..504
FT                   /note="C-type lectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          527..643
FT                   /note="C-type lectin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          677..808
FT                   /note="C-type lectin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          831..950
FT                   /note="C-type lectin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          978..1106
FT                   /note="C-type lectin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1131..1242
FT                   /note="C-type lectin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1271..1391
FT                   /note="C-type lectin 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          1446..1479
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19656770"
FT   CARBOHYD        363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19656770"
FT   CARBOHYD        1028
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1348
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        92..111
FT                   /evidence="ECO:0000250"
FT   DISULFID        186..212
FT                   /evidence="ECO:0000250"
FT   DISULFID        200..227
FT                   /evidence="ECO:0000250"
FT   DISULFID        265..358
FT                   /evidence="ECO:0000250"
FT   DISULFID        334..350
FT                   /evidence="ECO:0000250"
FT   DISULFID        409..503
FT                   /evidence="ECO:0000250"
FT   DISULFID        480..495
FT                   /evidence="ECO:0000250"
FT   DISULFID        617..634
FT                   /evidence="ECO:0000250"
FT   DISULFID        703..807
FT                   /evidence="ECO:0000250"
FT   DISULFID        784..799
FT                   /evidence="ECO:0000250"
FT   DISULFID        852..949
FT                   /evidence="ECO:0000250"
FT   DISULFID        926..941
FT                   /evidence="ECO:0000250"
FT   DISULFID        1077..1097
FT                   /evidence="ECO:0000250"
FT   DISULFID        1219..1233
FT                   /evidence="ECO:0000250"
FT   DISULFID        1367..1382
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        1141
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBG0"
FT   VAR_SEQ         173..180
FT                   /note="EVYTIQGN -> GEGSIAKS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017223"
FT   VAR_SEQ         181..1479
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_017224"
FT   CONFLICT        66
FT                   /note="V -> F (in Ref. 1; AAC52729)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        519
FT                   /note="G -> D (in Ref. 1; AAC52729)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        869
FT                   /note="D -> G (in Ref. 1; AAC52729)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        984
FT                   /note="R -> Q (in Ref. 4; BAC98005)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1479 AA;  167074 MW;  AFC78624FE331E32 CRC64;
     MVPIRPALAP WPRHLLRCVL LLGGLRLGHP ADSAAALLEP DVFLIFSQGM QGCLEAQGVQ
     VRVTPVCNAS LPAQRWKWVS RNRLFNLGAT QCLGTGWPVT NTTVSLGMYE CDREALSLRW
     QCRTLGDQLS LLLGARASNA SKPGTLERGD QTRSGHWNIY GSEEDLCARP YYEVYTIQGN
     SHGKPCTIPF KYDNQWFHGC TSTGREDGHL WCATTQDYGK DERWGFCPIK SNDCETFWDK
     DQLTDSCYQF NFQSTLSWRE AWASCEQQGA DLLSITEIHE QTYINGLLTG YSSTLWIGLN
     DLDTSGGWQW SDNSPLKYLN WESDQPDNPG EENCGVIRTE SSGGWQNHDC SIALPYVCKK
     KPNATVEPIQ PDRWTNVKVE CDPSWQPFQG HCYRLQAEKR SWQESKRACL RGGGDLLSIH
     SMAELEFITK QIKQEVEELW IGLNDLKLQM NFEWSDGSLV SFTHWHPFEP NNFRDSLEDC
     VTIWGPEGRW NDSPCNQSLP SICKKAGRLS QGAAEEDHGC RKGWTWHSPS CYWLGEDQVI
     YSDARRLCTD HGSQLVTITN RFEQAFVSSL IYNWEGEYFW TALQDLNSTG SFRWLSGDEV
     IYTHWNRDQP GYRRGGCVAL ATGSAMGLWE VKNCTSFRAR YICRQSLGTP VTPELPGPDP
     TPSLTGSCPQ GWVSDPKLRH CYKVFSSERL QEKKSWIQAL GVCRELGAQL LSLASYEEEH
     FVAHMLNKIF GESEPESHEQ HWFWIGLNRR DPREGHSWRW SDGLGFSYHN FARSRHDDDD
     IRGCAVLDLA SLQWVPMQCQ TQLDWICKIP RGVDVREPDI GRQGRLEWVR FQEAEYKFFE
     HHSSWAQAQR ICTWFQADLT SVHSQAELDF LGQNLQKLSS DQEQHWWIGL HTLESDGRFR
     WTDGSIINFI SWAPGKPRPI GKDKKCVYMT ARQEDWGDQR CHTALPYICK RSNSSGETQP
     QDLPPSALGG CPSGWNQFLN KCFRIQGQDP QDRVKWSEAQ FSCEQQEAQL VTIANPLEQA
     FITASLPNVT FDLWIGLHAS QRDFQWIEQE PLLYTNWAPG EPSGPSPAPS GTKPTSCAVI
     LHSPSAHFTG RWDDRSCTEE THGFICQKGT DPSLSPSPAA TPPAPGAELS YLNHTFRLLQ
     KPLRWKDALL LCESRNASLA HVPDPYTQAF LTQAARGLQT PLWIGLASEE GSRRYSWLSE
     EPLNYVSWQD EEPQHSGGCA YVDVDGTWRT TSCDTKLQGA VCGVSRGPPP RRINYRGSCP
     QGLADSSWIP FREHCYSFHM EVLLGHKEAL QRCQKAGGTV LSILDEMENV FVWEHLQTAE
     AQSRGAWLGM NFNPKGGTLV WQDNTAVNYS NWGPPGLGPS MLSHNSCYWI QSSSGLWRPG
     ACTNITMGVV CKLPRVEENS FLPSAALPES PVALVVVLTA VLLLLALMTA ALILYRRRQS
     AERGSFEGAR YSRSSHSGPA EATEKNILVS DMEMNEQQE
//
